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not) and also with increasing body size (whether adjusted forThe urea {clearance 3 dialysis time} product (Kt) as an outcome-
Kt or not) for each estimate of size. Significant statistical inter-based measure of hemodialysis dose.
actions of Kt with gender, but not Kt with race, were observedBackground. The normalized treatment ratio [Kt/V 5 the
ratio of the urea {clearance 3 time} product to total body in all models. There were no statistical interactions, suggesting
water] and the urea reduction ratio (URR) have become widely that higher Kt was routinely required with increasing body
accepted measures of dialysis dose. Both are related to and size. Separate risk profiles for males and females suggested a
derived from pharmacokinetic models of blood urea concentra- higher Kt threshold for males.
tion during the dialysis cycle. Theoretical reconsideration of Conclusions. The urea {clearance 3 time} is a valid outcome-
the models revealed that the premise about V on which they based measure of dialysis dose and is not confounded by in-
rest (that is, that V is a passive diluent with no survival-associ- dexing it to an estimate of body size, which has outcome-
ated properties of its own) is flawed if the intended use of the associated properties of its own. Dialysis prescriptions for
models is for profiling clinical outcome (for example, mortality) males and females should be regarded separately, but there
rather than estimating urea concentration. As a proxy for body appears no need to make a distinction between the races.
mass, V has survival-associated properties of its own. Thus,
indexing {clearance 3 time} to body size could create an off-
setting combination whereby one measure favorably associated
with survival (Kt) is divided by another (for example, V). The primary finding [1] and final report [2] of the
Observed clinical paradoxes support that interpretation. For National Cooperative Dialysis Study (NCDS) were pub-example, patients with a low body mass have both higher URR
lished more than 15 years ago. That study evaluated fourand higher mortality than heavier patients. Increasing mortality
groups of patients arranged in a 2 3 2 factorial designis often observed at high URR, suggesting the possibility of
“over-dialysis.” Black patients tend to be treated at lower URR [3] where blood urea nitrogen (BUN) concentration, a
than whites but enjoy better survival on dialysis. Therefore, proxy for “small molecule”-directed therapy, and the
{clearance 3 time} was evaluated as an outcome-based measure
length of the dialysis treatment, a proxy for therapyof dialysis dose, not indexed to V, and various body size esti-
directed at larger molecules, were the factors [3, 4]. Amates were evaluated as separate and distinct measures.
Methods. The retrospective sample included 17,141 black computer-assisted, single-pool, variable-volume urea ki-
and white hemodialysis patients treated three times per week. netic model [5–7] was used to facilitate the control of
Logistic regression analysis was used to evaluate death odds in
BUN at two levels (low and high) within two levels ofage-, gender-, race-, and diabetes-adjusted models. Kt and five
dialysis time (long and short). The urea kinetic equationsbody size estimates (total body water or V, body weight, body
weight adjusted for height, body surface area, and body mass can be solved to estimate BUN at the end of dialysis
index) were evaluated using two analytical strategies. First, all in terms of the predialysis BUN and the ratio (Kt/V:
of the measures were treated as continuous variables to explore dimensionless) of total clearance (Kt:ml) to the ureadifferent statistical models. Second, Kt and the body size mea-
volume of distribution (V:ml) that is presumed to equalsures were divided into groups to construct risk profiles.
Results. All evaluations revealed improving death odds with total body water (TBW). Here, K means urea clearance
increasing Kt (whether adjusted for the body size estimates or (ml/min), and t means the length of the dialysis treatment
(min). Kt/V was high in the two low-BUN groups of the
NCDS [8]; it was low in the two high-BUN groups. BUNKey words: dialysis dose, renal failure, ESRD, body surface area, hu-
man studies. was successfully controlled within the protocol-pre-
scribed limits in both the pilot [9, 10] and the final study
Received for publication December 31, 1998
[11]. The results of the NCDS suggested that therapyand in revised form March 4, 1999
Accepted for publication March 15, 1999 directed toward the control of small molecule concentra-
tion, such as BUN, was more closely associated with 1999 by the International Society of Nephrology
729
Lowrie et al: Kt as a measure of dialysis dose730
morbidity than was the length of the dialysis treatment reflect poor nutritional status and contribute to both
higher URR and higher mortal risk.[1, 12].
Third, Owen and Price noticed that URR tended to beA secondary analysis [13] of the NCDS database in
low among blacks compared with whites [22]. However,terms of Kt/V, rather than the four treatment groups,
blacks enjoy better survival on dialysis than whites.suggested that medical failure rates, as defined by the
Owen et al also reported that the relationship of mortalstudy protocol, were acceptable and stable when Kt/V
risk to URR appeared much less steep among blacksexceeded 0.8. Below that threshold, they appeared to
than whites [23]. The relationships between mortal riskbecome precipitously worse as a “step function” after
and both serum albumin concentration and serum creati-which they were again stable. Thus, therapy was re-
nine concentration, on the other hand, were similar be-garded as a step function, that is, it was adequate when
tween the races. The data suggest that indexing treat-1.0 liter of total clearance (Kt) was administered for each
ment exposure (Kt) to a measure associated withliter of body water (V) during each dialysis treatment.
nutritional status (V) could blunt the apparent deathThe ratio Kt/V, called “normalized therapy” [13], there-
risk sensitivity of blacks to dialysis dose, as estimated byfore indexed total treatment to TBW and was deemed
the URR or Kt/V.adequate when the ratio exceeded 1.0. The analysis and
The serum creatinine concentration tends to be higherthe interpretation of it were accepted widely by the dial-
among blacks than whites [24] and, like serum albuminysis community [14, 15]. Evaluation of dialysis dose by
concentration, is favorably associated with survival amongthe urea kinetic construct became the standard and re-
hemodialysis [17, 19, 25] and peritoneal dialysis [26] pa-mains so today, although the Kt/V threshold has crept
tients. It is thought to reflect in part lean body mass amongupward from 1.0 [15].
dialysis patients [17, 25]. Survival on dialysis improvesThe fractional fall of BUN caused by a dialysis treat-
progressively with increasing body mass, expressed ei-ment [the urea reduction ratio (URR:%)] is frequently
ther as a fraction of desirable weight [17, 21, 27] or asused to judge dialysis dose because the urea kinetic equa-
weight adjusted or not for height [21, 28]. Better survivaltions are used to calculate BUN at the end of dialysis
among blacks could be due to better nutritional status.from the predialysis concentration. Also, Kt/V is esti-
Those observations suggested that the urea kinetic con-mated clinically by measuring the predialysis and postdi-
struct for dialysis dose, Kt/V or URR, whereby one mea-alysis BUN. Retrospective analyses of large clinical data-
sure favorably associated with survival (Kt) is divided bybases [16–19] demonstrated an inverse association of the
another (V, a proxy for lean body mass), could be flawedodds ratio for death with URR. The threshold below
[23, 28]. We therefore evaluated the {clearance 3 time}which odds appeared to deteriorate was approximately
product (Kt) and different estimates of body mass as60% [18–20], although the recommended threshold has
separate and independent measures. In other words, wesince crept upward [15].
separated Kt from V rather than normalizing or indexingThree recent observations suggested clinical problems
Kt for V as a single quantity or ratio. We propose thatand paradoxes when medical outcome was considered
Kt is a better outcome-based measure of dialysis dosein terms of URR. First, Kopple et al reported progressive
than Kt/V because it better reflects the clinical realitydeterioration of survival among patients grouped by
that dialysis exposure and body mass are associated inde-height for weight percentile in persons smaller than the
pendently with survival.
50th percentile (abstract; Kopple et al, J Am Soc Nephrol
8:198A, 1997) [21]. However, URR decreased progres-
METHODSsively with increasing weight for height percentile so that
the lightest patients had both the highest URR and the Data described earlier were supplemented by adding
highest odds of death. The data, taken alone, could suggest height and weight to the analytical files [23]. The sample
that high URR caused undernutrition and increased risk. of patients was taken from the Fresenius Medical Care
Second, Chertow et al found that mortal risk tended to (NA) (Lexington, MA, USA; formerly National Medical
increase when URR was high (more than approximately Care, Inc.) Patient Statistical Profile system. The data-
70%), producing a reversed “J-shape” to the URR death base and methods of abstraction have been described
risk profile (abstract; Chertow et al, J Am Soc Nephrol previously [17–19, 23]. On January 1, 1994, patients who
8:279A, 1997). TBW was measured by bioelectrical im- were receiving hemodialysis three times per week and
pedance in 3009 patients; high URR was associated with who lived the entire year on dialysis or died during the
low TBW. Indeed, adjusting URR for TBW produced year were selected. Only patients with values for date
a smooth, monotonic death risk profile, suggesting that of birth, race, gender, diabetic status, and body height
higher URR was associated with better survival across were eligible for analysis. Values of the URR, predialysis
the entire range of TBW-adjusted URR. The data sug- albumin concentration, predialysis serum creatinine con-
centration, and postdialysis body weight were averagedgested that low lean body mass and, therefore low TBW,
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by patient for the last three months of 1993 and were P , 0.001) and tended to be higher in males than females
and greater in blacks than whites (Ps , 0.001). Similarused in these analyses. Only white and black patients
with complete data were accepted. The final sample in- differences were observed for BSA (F 5 1196, P ,
0.001). BMI was different among the clusters (F 5 83.1,cluded 17,141 patients.
The URR was calculated as the fractional fall [(predi- P , 0.001). BMI was greater for black females than the
others (P values , 0.001). Black and white males werealysis 2 postdialysis)/predialysis] of the BUN concentra-
tion during dialysis and expressed as a percentage [8, not different, and neither were black males and white
females. BMI among whites was greater for females than18]. The patients’ values for TBW were estimated by the
formula of Chertow et al [29]. URR was transformed to males.
Serum creatinine concentration differed among thethe total treatment clearance (that is, Kt) to volume (V)
ratio (Kt/V) by taking the negative loge of one minus clusters (F 5 1646, P , 0.001). Blacks had higher creati-
nine than whites and within the races, and males hadthe URR divided by 100 [8]. Kt, defined as the product
of the dialyzer clearance and the length of the dialysis higher values than females. All means were different
from each other (P values , 0.01). Serum albumin con-treatment, was estimated by multiplying Kt/V by TBW.
Body surface area (BSA) was estimated by the equation centration also differed among the groups (F 5 136, P ,
0.001). All differences among the clusters were signifi-of Du Bois and Du Bois [30]. The body mass index (BMI)
was calculated as Que´tlet’s relationship, the ratio of cant (P , 0.001), even though the numerical differences
were small. Males had higher albumin than females, andweight (kg) to the square of height (m2) [31]. Laboratory
determinations were performed in a single laboratory blacks had higher albumin than whites.
The URR values differed among the clusters (F 5(LifeChem Clinical Laboratories, Rockleigh, NJ, USA).
The primary statistical tool was logistic regression 538, P , 0.001). Males were treated at lower URR values
than females. Black males were treated at the lowestanalysis [32]. Two strategies were employed. First, mod-
els treating Kt and several estimates of body mass (TBW, URR, whereas white females were treated at the highest.
All means differed from the others (Ps , 0.001). LikeBSA BMI, body weight, and body weight adjusted for
URR, Kt/V was lower in males than females and lowerbody height) were treated as continuous measures. Sta-
in blacks than whites. All groups differed significantlytistical modeling proceeded in a progressive manner by
from the others. Kt, on the other hand, was higher amongevaluating the primary variables and potential interac-
males than females and was higher in whites than blackstions among them noting both the significance of the
(F 5 556, P , 0.001; all intergroup P values , 0.001).measure and improvement of the log likelihood ratio. All
models included age, race, gender, and diabetic status.
Dialysis dose and other clinical measuresSecond, Kt and the body size measures were ranked into
Table 2 gives certain correlation coefficients amongquintiles to construct unbiased risk profiles. All analyses
the treatment, body size, and biochemical measures. Thewere adjusted for contemporaneous values such as age,
URR was associated inversely with body weight (r 5diabetes, race, and gender when appropriate. Compari-
20.33, P , 0.001), TBW (r 5 20.38, P , 0.001), BMIsons of certain means among the race 3 gender clusters
(r 5 20.19, P , 0.001), and BSA (r 5 20.36, P , 0.001).were performed using two-way analyses of variance; tests
It was also inversely correlated with serum creatininebetween groups were by Bonferroni’s method. Bivariate
concentration (r 5 20.22, P , 0.001) and serum albuminregression analyses were performed using the method
concentration (r 5 20.016, P 5 0.042). A higher URRof least squares. Correlation coefficients are given as
was associated with lower albumin, albeit marginally so.Pearson’s product moment.
Both albumin (r 5 0.10, P , 0.001) and creatinine (r 5
0.11, P , 0.001) were directly associated with Kt. Kt was
RESULTS also directly correlated with all of the body size measures
Table 1 summarizes the anthropometric and treatment (rweight 5 0.37; rBMI 5 0.14; rBSA 5 0.43; rTBW 5 0.46; Ps ,
statistics among the four race 3 gender clusters. Approx- 0.001). TBW, like Kt, was directly correlated with both
imately one fourth of the patients were in each of the creatinine (r 5 0.35, P , 0.001) and albumin (r 5 0.16,
four clusters. The average ages for black males and fe- P , 0.001). Both albumin and creatinine were directly
males and white males and females were 54.9 (614.6 correlated with each other and the other body size mea-
sd), 60.0 (614.1), 62.1 (615.0), and 63.1 (614.1), respec- sures. Thus, the anthropometric estimates of body size
tively (F 5 266, P , 0.001). were directly correlated with the biochemical proxies for
The weight differences among the clusters were sig- nutritional health. Kt was directly correlated with both
nificant (F 5 345, P , 0.001). Males tended to be heavier the body size estimates and the biochemical proxies,
than females and blacks heavier than whites. All groups unlike the URR that was inversely associated with them.
were statistically different from each other (P values , Advancing age was associated with higher URR (r 5
0.15, P , 0.001). On the other hand, age was associated0.001). TBW also differed among the clusters (F 5 4140,
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Table 1. Physical, biochemical and treatment values by gender and race
Males Females
All
Black White Black White patients
Number 4,174 4,516 4,451 4,000 17,141
Weight kg 76.1618.2 73.3616.3 69.6618.4 64.2616.5 70.9617.9
Body water liters 46.167.5 44.367.0 35.665.1 33.864.7 40.068.2
BSA m 2 1.9160.22 1.8660.21 1.7460.22 1.6660.20 1.7960.23
BMI kg/m 2 24.765.6ab 24.565.0a 26.366.8 25.066.1b 25.165.9
Creatinine mg/dl 13.763.8 10.563.2 11.163.0 8.962.5 11.163.6
Albumin g/dl 3.8960.39 3.8460.36 3.7960.35 3.7360.35 3.8160.36
URR % 59.668.2 62.067.6 63.868.2 66.467.5 62.968.2
Kt/V 0.9360.22 0.9960.21 1.0560.25 1.1260.23 1.0260.24
Kt liters 42.5610.7 43.4610.1 36.968.9 37.367.9 39.069.9
Data are means 6 sd. All means between the race 3 gender clusters were significantly different from each other except those accompanied by the same superscript
letters (P values , 0.05). Abbreviations are: BSA, body surface area; BMI, body mass index; URR, urea reduction ratio; Kt/V, total clearance per liter of body
water, dialysis dose.
Table 2. Correlation coefficients among treatment, biochemical, but not for BSA. Significant interactions between race
and anthropometric measures
and body weight, BMI, and BSA but not TBW were
URR Kt Creatinine Albumin observed. The coefficients suggest that black patients
may have been more sensitive to low body mass thanWeight 20.32 0.37 0.27 0.11
BSA 20.36 0.43 0.31 0.13 white patients, even though body mass tended to be
TBW 20.38 0.46 0.35 0.16 greater among blacks than whites.BMI 20.19 0.14 0.14 0.05
There were no significant interactions between Kt andCreatinine 20.22 0.11 1 0.36
Albumin 20.02a 0.10 0.36 1 body weight, weight adjusted for height, BSA, or TBW.
All P values , 0.001 except a mean P 5 0.042. A significant (P 5 0.042) interaction between Kt and
BMI was observed. The coefficient associated with that
term, however, suggested an off-setting effect whereby
lower Kt was required for the same odds of death as BMI
inversely, but weakly, with Kt (r 5 20.03, P , 0.001). increased, all else being equal. Thus, we were unable to
Age was also associated inversely with TBW (r 5 20.20, find convincing evidence suggesting that greater Kt was
P , 0.001), as well as body weight (r 5 20.15, P , 0.001), required with increasing body size within the domains
BMI (r 5 20.08, P , 0.001), and BSA (r 5 20.16, P , of data available to us and given the statistical adjust-
0.001). The findings suggest that the higher URR observed ments for race and gender made to these models.
with advancing age was due more to declining lean body Grouped measure analysis. Figure 1 illustrates the risk
mass than it was to more intense dialysis exposure. profiles for Kt adjusted and not adjusted for the body-
size measures taken over all patients. The Kt profile{Clearance 3 time} and mortality
suggests smooth, monotonic improvement of death odds
Continuous measure analysis. Table 3 summarizes the through the fourth quintile (41.2 , Kt # 47.3 liter/treat-
results of six logistic regression models evaluating Kt ment), after which it appeared to flatten.
alone and combined with body weight, weight adjusted Figure 2 shows the risk profiles for TBW, body weight
for height, BSA, BMI, and TBW. The coefficients associ- (not adjusted for height), BSA, and BMI adjusted and
ated with Kt suggested improving death odds with in- not adjusted for Kt. The odds ratios associated with body
creasing Kt. Significant quadratic (that is, second order, weight adjusted for height for the first, second, third,
Kt2) effects were associated with Kt, suggesting that the fourth, and fifth quintiles of weight were 2.56, 1.73, 1.19,
rate of death odds improvement tended to level or pla- 1.0 (reference), and 0.89 without adjustment for Kt (all
teau as Kt increased. There was a significant Kt by gender P values , 0.05 except associated with 0.89, P 5 NS).
interaction in each model; there were no Kt by race Similar values after adjustment for Kt were 2.32, 1.63,
interactions. 1.15, 1.0 (reference), and 0.94 Kt (all P values , 0.05
The coefficients associated with body weight (whether except associated with 0.94, P 5 NS; data not shown).
adjusted for height or not), BSA, BMI, and TBW suggest Therefore, improvement of survival with increasing val-
that lower values of each were associated with greater ues appeared to be smooth and monotonic throughout
odds of death. Significant quadratic effects suggested a the ranges of all the body mass measures, whether ad-
flattening of the association at higher values of body justed for coexisting values of Kt or not. That was partic-
ularly true for BSA.weight (whether adjusted for height or not), BMI, TBW
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Table 3. Total treatment clearance (Kt) models using different anthropometric adjustments to determine
the table of logistic regression coefficientsa
Adjustments Weight and
parameter None Weight height BSA BMI TBW
Age 0.0316 0.0293 0.0300 0.0293 0.0298 0.0289
Gender (Ref 5 male) 0.5754c 0.2533c 0.4289c 0.3745c 0.4738c 0.2259c
Race (Ref 5 black) 0.2708 20.4180b 20.3719b 20.7611b 20.5198 0.2222
Diabetes (Ref 5 no) 0.3345 0.4346 0.4572 0.3838 0.4520 0.4039
Kt liter 20.0494 20.0358 20.0417 20.0377 20.0562b 20.0373
Kt2 liter 2 0.0002 0.0002b 0.0002 0.0002b 0.0002 0.0002b
Gender 3 Kt 20.0466 20.0371b 20.0378b 20.0423 20.0386b 20.0429
Gender 3 Kt2 0.0006 0.0005 0.0005 0.0006 0.0005 0.0006
Weight kg NA 20.0594 20.0671 NA NA NA
Weight2 kg 2 NA 0.0002 0.0003 NA NA NA
Race 3 weight NA 0.0094 0.0091 NA NA NA
Height cm NA NA 0.0190 NA NA NA
BSA m2 NA NA NA 21.2845 NA NA
Race 3 BSA NA NA NA 0.5601 NA NA
BMI kg/m 2 NA NA NA NA 20.1874 NA
BMI2 kg/m 2 NA NA NA NA 0.0016 NA
Race 3 BMI NA NA NA NA 0.0319 NA
Kt 3 BMI NA NA NA NA 0.0007b NA
TBW liter NA NA NA NA 20.0825
TBW2 liter 2 NA NA NA NA 0.0006b
a All P values , 0.01 except b means 0.01 # P , 0.05 and c means P . 0.10. NA is not applicable.
Fig. 1. Risk profiles by quintile of {clearance 3
time} (Kt), adjusted and not adjusted for the
body size measures. The P values over the
bars indicate the significance of the odds ratio
compared with the appropriate reference
group. The value over a single bar indicates
that the P value was outside of the range indi-
cated for the others in the quintile. Symbols
are: (j) none; ( ) body mass index (BMI);
( ) weight 1 height (wt 1 ht); ( ) weight;
( ) total body water (TBW); (h) body sur-
face area (BSA).
The robust statistical interactions between Kt and gen- cal reality. The implications of all such models here,
der, but not Kt and race, suggested the need to evaluate however, were similar. Several estimates of body size
the genders separately. Figure 3 shows those risk profiles. were evaluated with {clearance 3 time}. The data con-
The profile for males appeared to flatten at somewhat firm and extend earlier observations [28], suggesting that
higher values (fourth quintile; 41.2 to 47.3 liter/treat- higher Kt and greater body size are favorably and inde-
ment) than that for females (third quintile; 37.0 to 41.2 pendently associated with death odds. Higher values of
liter/treatment), and the odds ratios associated with low both were associated with lower odds of death. Con-
{clearance 3 time} were greater for males. structing risk profiles from grouped data supported com-
parable interpretation.
DISCUSSION Although increasing values of {clearance 3 time} were
associated with improved survival, significant quadraticIt is often difficult to say with certainty which of a
number of possible statistical models best describes clini- effects suggested a leveling, or plateau, effect at higher
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Fig. 3. Risk profiles for {clearance 3 time} for (A) males and (B) females. The risk profiles are shown not adjusted and also adjusted for the
body size measures. No fewer than 10% of males or females were in any Kt group. The value over a single bar indicates that the P value was
outside of the range indicated for the others in the quintile. Symbols are: (j) none; ( ) body mass index (BMI); ( ) weight 1 height (wt 1 ht);
( ) weight; ( ) total body water (TBW); (h) body surface area (BSA).
Kt. A leveling effect as Kt increased was also observed We did not include body size measurements in statisti-
cal models with the URR as part of either this or thein the risk profiles. Significant statistical interactions of
earlier effort [23]. URR is related to and linked mathe-{clearance 3 time} with gender were observed in each
matically with the urea kinetic parameter, Kt/V. Theof the six models. The risk profiles for males and females
ratio conceptually “normalizes” treatment to V, TBWsuggested similar interpretation whether adjusted for the
[13]. Thus, V, a proxy for body size, is already part ofbody size measures or not. There were no statistical inter-
that measure.actions between Kt and race as there were between URR
Two lines of evidence, using different data sets, suggestand race during earlier investigations of these data [23].
that indexing treatment to body size may not be appro-All of the body size measures were associated with
priate. First, Chertow et al included measures of TBWdeath odds whether adjusted for contemporaneous val-
in statistical models with URR and eliminated the re-ues of {clearance 3 time} or not. Greater size was associ-
versed J-shape of the URR risk profile (abstract; Cher-ated with lower odds of death. There was also a signifi-
tow et al, J Am Soc Nephrol 8:279A, 1997). The findingcant quadratic effect for each of the measures, except
suggested that the increased risk frequently observed atTBW, suggesting a leveling effect as body size increased.
high URR, or Kt/V, was due to undernutrition and notThe risk profiles were compatible with the implications
over dialysis.of the statistical models.
Second, recent studies from the United States RenalThere were no interactions between Kt and the body
Data System evaluated Kt/V and certain body size mea-
size measures that suggested higher Kt was required as sures in the same statistical model (abstract; Wolfe et
body size increased to achieve comparable levels of risk. al, J Am Soc Nephrol 9:230A, 1998). They concluded
To the contrary, the interaction between Kt and BMI that Kt/V and body size (including V) were indepen-
suggested lower Kt at comparable odds as BMI in- dently and significantly associated with survival. The re-
creased. The finding may have resulted from low mortal- lationship of Kt/V to death risk among tertiles of body
ity among blacks, especially black females, who had low size was evaluated. Patients with lower body size re-
mortality [23] and high BMI. The BMI is more of a quired higher Kt/V to achieve the same level of risk.
measure of adiposity than it is a measure of body mass Thus, dividing Kt by V failed to “normalize” treatment
[33]. Tall, muscular persons, for example, can have great across all classes of body size with respect to the amount
body mass (that is, weight in kg) but average or low of treatment required for a particular outcome, as such
BMI; short, fat people can have relatively low body mass indexing techniques are intended to do [34]. Instead, it
accentuated them.but a high BMI.
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Turner and Reilly explored the statistical implications is compromised. Because Kt/V is the product of a model
that is based on a false premise, then it has limited au-associated with the practice of indexing certain renal and
hemodynamic data to BSA [34]. Indexing is intended thority as an outcome-based measure of dialysis dose.
The false premise about the inert properties of V em-to eliminate the possible dependence of physiological
measures on body size. In fact, it failed to eliminate them, bodied in the urea kinetic models gives rise to clinical
problems and paradoxes when mortality is consideredand often created new and unintended dependencies of
the indexed measures (for example, measure/BSA) on in terms of Kt/V or the URR. Blacks enjoy better survival
on dialysis than whites but are treated at lower URRBSA. Toth et al evaluated indexing peak oxygen uptake
to fat-free body mass as a ratio during cardiovascular than whites. They tend to have greater body mass than
whites and thus enjoy better survival associated withperformance testing [35]. They found that indexing led
to a spurious difference between the genders that did better nutritional status; they are not insensitive to the
effects of azotemia or dialysis [23]. The increase of mor-not exist when regression methods were used to make
adjustments for body size. The artifact was caused by tality frequently seen at high URR in URR risk profiles
is due to smaller body size among those patients and notfailure of the indexing ratio to recognize a nonzero inter-
cept in the relationship between uptake and body mass. to “over dialysis.” Patients in the lower weight for height
percentiles have both higher URR and higher mortalityTherefore, indexing can lead to inaccurate inferences
about differences between subgroups of a population than patients in the higher percentiles [21], because low
body mass permits higher URR and contributes to highermuch as it did with respect to the differences in the
association of dialysis dose, expressed as the URR, with mortality. All of those problems and paradoxes can be
understood and managed if Kt/V is disaggregate intomortality between blacks and whites [23].
Turner and Reilly explained that if a linear relation- two separate, outcome-based measures: dialysis expo-
sure and body mass.ship exists between two quantities (for example, between
some physiological measure and BSA), a slope, an inter- Our analyses fail to demonstrate a clear and convinc-
ing requirement for unlimited increase of {clearance 3cept, and an error term describe it [34]. Values for the
slope and intercept can be estimated by using statistical time} with increasing body size. They do, however, sug-
gest gender differences that may be related in part totechniques such as the least-squares method. Indexing
methods assume a single, uniform slope and an intercept body size. Future, prospective investigations should at-
tempt to evaluate possible body size relationships sepa-value that is equal to zero. The assumed values for slope
and intercept may be incorrect under certain circum- rately for the genders. Such efforts should explore non-
linear relationships with nonzero intercepts rather thanstances or for particular populations. Thus, computa-
tional artifacts can lead to inaccurate inferences when fixed ratios such as 1.0, 1.2, or 1.4, as is now the practice
when using Kt/V [15].indexed measures are used. In contrast, regression meth-
ods do not require any particular assumptions about Minimum {clearance 3 time} thresholds of 40 to 45
liter/treatment and 45 to 50 liter/treatment three timesslope or intercept values and thus are not vulnerable to
those errors. They [34] and others [35–37] recommended weekly for females and males, respectively, can be in-
ferred from these retrospective data. However, therethat indexing methods be abandoned in favor of regres-
sion methods for describing and evaluating physiological can be no assurance that higher values may not yield
incremental benefit once such data are available and aremeasurements in terms of body size.
The potential problems associated with indexing thoroughly evaluated.
The possible independent effects of clearance and time{clearance 3 time} to V extend well beyond those statisti-
cal concerns, however, to more basic structures. The require further investigation. The incremental contribu-
tion of time to treatment failure in the NCDS [13, 15]ratio, Kt/V, derives its authority from its origin in the
urea kinetic model that is a mathematical construct [5–7, has been largely ignored; it is not convenient to utilize
the kinetics-based dialysis prescription with the current13]. The fundamental premise about the properties of
V assumed by the models views it only as an excipient, models. However, the independent associations of time
with treatment failure in the NCDS were marginallyan inert diluent, for urea. However, V is a proxy for body
mass and therefore nutritional status. These findings and significant (P 5 0.06) [1]. Indeed, the final recommenda-
tion of the NCDS suggested that short dialysis timeothers show that body mass has properties associated
with survival [17, 21, 27]. Thus, the premise about V, should be prescribed with caution, particularly in pa-
tients who are likely to suffer from cardiovascular diseaseon which the kinetic equations rest, is valid only if the
equations are used to evaluate BUN concentration. [12]. Entirely ignoring time with such a small (151) sam-
ple of patients is probably unwise in light of its nearThese data and analyses [28] suggest that it may not be
valid if the context for use is to evaluate, predict, or statistical significance. The relative contribution of dial-
ysis exposure and residual renal function to survival alsomanipulate the survival of patients. If the premises of a
model do not support its intended use, then the model requires more careful investigation. Similarly, the fre-
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